A medical laboratory needs more than one way to know whether its results are reliable. Internal quality control (IQC) helps identify instability or unexpected change within a testing process. External quality assessment (EQA) gives an independent comparison of performance beyond the laboratory. Both provide useful evidence, but neither can guarantee that every patient result is correct.
The distinction matters because apparently reassuring data can conceal different risks. A method might produce stable control results while showing a systematic difference from other laboratories. An EQA result might be satisfactory even though the laboratory experiences intermittent problems between assessment rounds. A strong quality system uses these signals together and interprets them in the context of clinical use.
At a glance: Internal quality control (IQC) monitors analytical performance within a laboratory over time, while external quality assessment (EQA) compares results with external targets or peer groups according to a scheme. Both provide useful but different evidence. Passing an EQA event does not replace routine IQC or a laboratory’s broader quality management responsibilities.
What IQC can tell a laboratory
IQC generally involves measuring selected control materials under defined conditions, evaluating their results against established expectations and taking action when the results indicate a possible problem. Depending on the method, laboratories may use several control levels, statistical rules, trends and frequency schedules.
For example, a clinical chemistry analyser might show a gradual change in a control result after a reagent or calibration event. The pattern may prompt investigation before the drift affects patient results. A sudden shift may suggest a different type of event. Recognising the signal depends on appropriate target values, variability estimates and rules chosen for the examination's performance needs.
IQC design is not one-size-fits-all. A routine high-volume quantitative assay may need a different strategy from a low-volume specialist method or a qualitative assay. Control frequency should reflect testing volume, analytical reliability, clinical risk and how quickly an undetected problem could affect patients.
CLSI C24 provides principles for planning statistical quality control of quantitative examination procedures. It does not prescribe a universal rule combination for every method, and its scope should not be stretched to cover all examination types without appropriate supporting guidance.
What EQA adds
EQA typically involves an external provider distributing material or cases to participating laboratories and evaluating returned results. It can highlight differences between laboratories, methods or peer groups, and can reveal problems that routine internal controls may not uncover.
A laboratory that performs well against its own control targets may still produce systematically different results from an appropriately comparable group. EQA can prompt investigation of calibration traceability, method bias, reporting units, interpretation or other aspects of the process.
EQA also has an educational role. UK NEQAS describes how its programmes support performance comparison, identification of common errors and continuous improvement. An unsatisfactory result is therefore an opportunity to investigate, not simply a score to file away.
EQA schemes vary. Some examine quantitative results, while others assess morphology, interpretation or clinical reasoning. The laboratory should choose schemes that are relevant to its actual examinations and understand the limits of the comparison. Differences in materials, methods and peer grouping may affect how a result should be interpreted.
Neither system replaces the other
IQC gives more frequent local monitoring but cannot always reveal whether the laboratory is aligned with appropriate external comparators. EQA provides useful external perspective but occurs periodically and may not detect transient problems between distributions.
An effective strategy considers the relationship between the two. If an EQA challenge shows unexpected bias, can the laboratory find a corresponding trend in IQC, calibration or patient-sample comparisons? If IQC indicates instability, could that affect how the next EQA result is interpreted? What additional evidence is needed before concluding that a method is fit for use?
Comparability of patient results may also matter across analysers, sites or platforms within a network. Split-sample exercises or other appropriate comparisons can supplement IQC and EQA, particularly when patients are monitored across different systems.
Make investigation and recovery part of the plan
Quality management does not end when a control fails. Staff need a defined process for withholding or reviewing results, establishing the affected time period, investigating potential causes and deciding whether previously issued reports require assessment or correction.
This can be operationally difficult in a busy laboratory. Clear responsibilities, escalation pathways and relevant electronic records are essential. A documented troubleshooting plan should help staff distinguish a control material issue from an analyser, reagent, calibration or process problem without simply repeating measurements until a pass appears.
Likewise, an unsatisfactory EQA performance should lead to a proportionate investigation, with documented conclusions, corrective actions and checks that those actions were effective. Repeatedly attributing poor performance to sample material without evidence weakens learning.
Use quality information to improve the service
Trend reviews can reveal recurring vulnerabilities: a particular reagent lot, an assay close to its clinical performance limits, frequent recalibrations or an unresolved difference between instruments. These patterns can inform procurement, maintenance, training, technical evaluation and service planning.
ISO 15189 establishes requirements for medical laboratory quality and competence, including arrangements for ensuring the validity of examination results. It provides a framework for governance, while method-specific guidance and local risk assessment shape the detail of the control strategy.
The goal is not to generate as many charts and EQA reports as possible. It is to ensure that quality evidence informs decisions, supports reliable reporting and triggers appropriate action when performance is in doubt.
Where Optymum SS fits: Optymum SS can support quality-system reviews, technical documentation, training resources and improvement planning. The laboratory remains responsible for its IQC and EQA programmes, quality decisions and the release of patient results.
Related on this site: Testing & Diagnostics, Education, Training & Professional Development.
Key takeaways
- Use IQC to monitor ongoing analytical stability.
- Use EQA to identify comparative performance concerns.
- Investigate signals in context and verify corrective actions.
Frequently asked questions
What is the difference between IQC and EQA?
IQC monitors the stability and acceptability of routine analytical performance using control materials. EQA provides external comparison and can help identify systematic performance problems.
Can good EQA performance replace daily IQC?
No. EQA is generally episodic and cannot substitute for the continuous or routine process monitoring appropriate to the assay and workload.
What should a laboratory do after an EQA failure?
Investigate the analytical process, peer-group comparisons, specimen handling, data entry and potential clinical impact, then document corrective action and its effectiveness.
